3billion, Inc. (KOSDAQ:394800)

Market Cap	221.17B +3.1%
Revenue (ttm)	11.71B +102.8%
Net Income	-5.41B
EPS	-171.00
Shares Out	31.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	320,645
Open	7,030.00
Previous Close	8,100.00
Day's Range	6,710.00 - 7,530.00
52-Week Range	5,520.00 - 20,100.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About 3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394800

Financial Performance

In 2025, 3billion's revenue was 11.71 billion, an increase of 102.85% compared to the previous year's 5.77 billion. Losses were -5.41 billion, -17.66% less than in 2024.